Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Antiretroviral Therapy within Two Years of HIV Acquisition is Associated with Fewer Viral Blips: A Retrospective Analysis of Over 20 Years of Data from the U.S. Military HIV Natural History Study
  2. Crowell, Trevor A; Hsieh, Hsing-Chuan; Wang, Xun; Chu, Xiuping; Gayle, Britt; Berjohn, Catherine M; Blaylock, Jason M; Yabes, Joseph M; Larson, Derek T; Powers,John; O'Connell, Robert J; Ganesan, Anuradha; Agan, Brian K
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2025, Mar 10;
  1. 2.   Virus maturation as a new HIV-1 therapeutic target
  2. Adamson, C. S.; Salzwedel, K.; Freed, E. O.
  3. Expert opinion on therapeutic targets. 2009, Aug; 13(8): 895-908.
  1. 3.   Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets
  2. Adamson, C. S.; Freed, E. O.
  3. Molecular Interventions. 2009, Apr; 9(2): 70-4.
  1. 4.   RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
  2. Shao, W.; Kearney, M.; Maldarelli, F.; Mellors, J. W.; Stephens, R. M.; Lifson, J. D.; KewalRamani, V. N.; Ambrose, Z.; Coffin, J. M.; Palmer, S. E.
  3. Retrovirology. 2009 6: 101.
  1. 5.   Synthesis of conformationally locked carbocyclic nucleoside phosphonates to probe the active site of HIV-1 RT
  2. Saneyoshi, H.; Vu, B. C.; Hughes, S. H.; Boyer, P. L.; Sarafianos, S. G.; Marquez, V. E.
  3. Nucleic acids symposium series (2004). 2008 (52): 623-4.
  1. 6.   Sphingolipids: Modulators of HIV-1 infection and pathogenesis
  2. Rawat, S. S.; Johnson, B. T.; Puri, A.
  3. Bioscience Reports. 2005, OCT; 25(5-6): 329-343.
  1. 7.   A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors
  2. Daelemans, D.; Pannecouque, C.; Pavlakis, G. N.; Tabarrini, O.; De Clercq, E.
  3. Molecular Pharmacology. 2005, MAY; 67(5): 1574-1580.
  1. 8.   Synthesis, resolution, and determination of the absolute configuration of the enantiomers of cis-4,5-dihydroxy-1,2- dithiane 1,1-dioxide, an HIV-1NCp7 inhibitor
  2. Mayasundari, A.; Rice, W. G.; Diminnie, J. B.; Baker, D. C.
  3. Bioorganic & Medicinal Chemistry. 2003 11(14): 3215-3219.
  1. 9.   HIV-Inhibitory prenylated xanthones and flavones from Maclura tinctoria
  2. Groweiss, A.; Cardellina, J. H.; Boyd, M. R.
  3. Journal of Natural Products. 2000 63(11): 1537-1539.
  1. 10.   N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes
  2. Le, Y. Y.; Jiang, S.; Hu, J. Y.; Gong, W. H.; Su, S. B.; Dunlop, N. M.; Shen, W. P.; Li, B. Q.; Wang, J. M.
  3. Clinical Immunology. 2000 96(3): 236-242.
  1. 11.   Structural and biochemical mechanisms of HIV-1 RT drug resistance
  2. Boyer, P. L.; Gao, H. Q.; Serafianos, S.; Ding, J.; Clark, P.; Clark, A.; Arnold, E.; Hughes, S. H.
  3. Conference on Retroviruses and Opportunistic Infections. 1999, 218 (abstract no. S33).
  1. 12.   Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor
  2. Prasad, J.; Boyer, F. E.; Domagala, J. M.; Ellsworth, E. L.; Gajda, C.; Hamilton, H. W.; Hagen, S. E.; Markoski, L. J.; Steinbaugh, B. A.; Tait, B. D.; Humblet, C.; Lunney, E. A.; Pavlovsky, A.; Rubin, J. R.; Ferguson, D.; Graham, N.; Holler, T.; Hupe, D.; Nouhan, C.; Tummino, P. J.; Urumov, A.; Zeikus, E.; Zeikus, G.; Gracheck, S. J.; Saunders, J. M.
  3. Bioorganic & Medicinal Chemistry. 1999 7(12): 2775-2800.
  1. 13.   Flow cytometric assay for HIV-1 whole virion binding: virus inactivated with aldrithiol-2 has binding properties comparable to native virions
  2. Esser, M. T.; Rossio, J. L.; Schneider, D. K.; Bess, J. W., Jr.; Grimes, M. K.; Henderson, L. E.; Arthur, L. O.; Lifson, J. D.
  3. HIV Pathogenesis and Treatment Conference. 1998, 86 (abstract no. 4024).
  1. 14.   Structure-based design of HIV protease inhibitors: pharmacokinetic optimization
  2. Stinson, S. F.; Randad, R. S.; Clanton, D.; House, T.; Lubkowska, L.; Erickson, J. W.
  3. HIV Pathogenesis and Treatment Conference. 1998, 56 (abstract no. 2039).
  1. 15.   Anti-HIV agents that selectively target the retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins
  2. Huang, M.; Turpin, J. A.; Graham, L.; Janini, G. M.; Covell, D. G.; Maynard, A.; Rice, W. G.
  3. Conference on Retroviruses and Opportunistic Infections. 1998, 200 (abstract no. 643).
  1. 16.   Identification of potential HIV-1 integrase (IN) inhibitors by co-localization of antiviral activity with integrase mediated events in the retroviral replication cycle
  2. Rice, W. G.; Schaeffer, C. A.; Bu, M.; Williamson, K.; Turpin, J. A.
  3. HIV Pathogenesis and Treatment Conference. 1998, 55 (abstract no. 2036).
  1. 17.   HIV replication persists in patients receiving HAART despite undetectable plasma virus
  2. Nata Rajan, V. N.; Chun, T. W.; O'Neill, D. P.; Metcalf, J. A.; Mican, J.; Engel, D.; Fauci, A. S.; Lane, H. C.; Kovacs, J. A.
  3. International Conference on AIDS. 1998, 12 341-2.
  1. 18.   New types of anti-HIV agents identified by the NCI drug discovery program. Eleventh International Conference on Antiviral Research
  2. Rice, W. G.; Turpin, J. A.; Huang, M.; Howard, O. M.; Michejda, C. J.; Bader, J. P.
  3. Antiviral Research. 1998 37(3): A58 (abstract no. 64).
  1. 19.   Azodicarbonamide (ADA) as an anti-HIV agent that targets the nucleocapsid protein zinc fingers: a clinical candidate
  2. Rice, W. G.; Turpin, J. A.; Summers, M. F.; Covell, D. G.; Sausville, E. A.
  3. Conference on Retroviruses and Opportunistic Infections. 1997, 105 (abstract no. 219).
  1. 20.   Identification of a novel bisimidazoacridone that inhibits HIV-1 replication by prevention of formation of post-integrative full-length RNA transcripts
  2. Turpin, J. A.; Williamson, K.; Schaeffer, C. A.; Bu, M.; Cholody, W. M.; Michejda, C. J.; Rice, W. G.
  3. Conference on Retroviruses and Opportunistic Infections. 1997, 106 (abstract no. 226).
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel